Nektar Therapeutics (NKTR) Tops Q3 EPS by 185c
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $74.02 -0.68%
Financial Fact:
License, collaboration and other: 8.37M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
License, collaboration and other: 8.37M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Nektar Therapeutics (NASDAQ: NKTR) reported Q3 EPS of $1.85. Revenue for the quarter came in at $11.79 million.
For earnings history and earnings-related data on Nektar Therapeutics (NKTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA maintains underperform ratings on six BDC stocks
- TD Cowen Assumes Nektar Therapeutics (NKTR) at Buy
- loanDepot receives NYSE non-compliance notice over stock price
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
